Group B streptococci continue to be a major cause of morbidity and mortality in neonates and in patients with compromised host defence mechanisms. ' 2 There are strain specific differences in opsonic requirements for type II 
VISUALISATION OF PHAGOCYTOSIS
Quantitation of ingestion of opsonised or unopsonised organisms was attempted by centrifuging the reaction mixture after recording chemiluminescence, removing the supematant, and resuspending the pellet in a drop of HBSS. An aliquot of this suspension was dropped on to a microscope slide and air dried; slides were fixed for 10 min in 100% methanol and stained with Giemsa (1/50 in buffered distilled water) for 1 h. The slides were examined microscopically under oil immersion (Fig. 1 ). An attempt to quantitate the degree of phagocytosis by counting the percentage of polymorphonuclear leucocytes ingesting or the number of bacteria ingested per polymorphonuclear leucocyte was extremely difficult, but there was a clear distinction between the appearance of preparations in which there had been phagocytosis and those in which no ingestion had occurred. In positive smears most of tions were used while keeping the number of group B streptococci III constant. Fig. 2 shows that opsonisation of group B streptococci is time dependent and that in normal sera a plateau is reached at 15 min. Fig. 2 lower numbers of bacteria. In contrast, higher numbers of organisms increased the peak in chemiluminescence. In subsequent assays the concentration of group B streptococci was adjusted so as to give a group B streptococci to polymorphonuclear leucocyte ratio of 200:1-that is, 1 x 109 organisms (optical density 0-9 at 620 nm). This ratio produced a significant but not a maximum chemiluminescence response. mal human serum following incubation in ToddHewitt broth supplemented with neuraminidase had no effect on phagocytosis. Opsonisation following incubation in Todd-Hewitt broth supplemented with 0 5 % trypsin, however, resulted in enhanced phagocytosis of all the serotypes and an increased chemiluminescence response, although resistant serotypes (lb and II) were not rendered fully sensitive to opsonophagocytosis, as shown by a, lower chemiluminescence response of these serotypes compared with the sensitive serotypes (Fig. 6) . None of the unopsonised serotypes treated with trypsin was phagocytosed to any appreciable extent and produced only a slight chemiluminescence response (Fig. 6) . Serotypes lb and II cultured in ToddHewitt broth supplemented with trypsin plus inhibitor (at all the concentrations used) were not opsonised to any appreciable extent and normal phagocytes challenged with these organisms failed to elicit a chemiluminescence response.
Effect on phagocytosis and luminol enhanced chemiluminescence response ofgroup B streptococci III opsonised with MgEGTA chelated serum and serum heated to 50°C for 20 min and 56°C for 30 min Fig. 7 shows the results of the experiments to determine the relative contributions of classical and alternative pathways of C3 activation to opsonisation of group B streptococci type III. Phagocytosis Hindocha, Hill, Wood, Patel, Hunt of group B streptococci III after opsonisation with serum chelated with MgEGTA was little affected, with no appreciable inhibition of chemiluminescence response. In contrast, phagocytosis after opsonisation with serum heated to 50°C for 20 min, leading to inactivation of factor B, resulted in reduced opsonisation with impaired phagocytosis and a diminished chemiluminescence response.
Discussion
The resistance to opsonophagocytosis by serotypes lb and II may be due to the fact that the antigenic determinants present in these serotypes are not immunologically "recognised" by serum opsonins and/or that they are incapable of activating the classical or alternative pathway of complement for effective opsonisation. Resistance 
